Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family

Infection and Immunity

Volumn 67, Issue 6, 1999, Pages 2941-2950

  Dillon, Davin C ^a   Alderson, Mark R ^a   Day, Craig H ^a   Lewinsohn, David M ^b   Coler, Rhea ^b   Bement, Teresa ^a   Campos Neto, Antonio ^b   Skeiky, Y A W ^a   Orme, Ian M ^c   Roberts, Alan ^c   Steen, Sean ^a   Dalemans, Wilfried ^d   Badaro, Roberto ^e   Reed, Steven G ^a,b,f  

^a GLAXOSMITHKLINE   (United States)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; T LYMPHOCYTE ANTIGEN; TUBERCULIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; GENETIC CONSERVATION; IMMUNIZATION; IMMUNOBLOTTING; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; MOUSE; MULTIGENE FAMILY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0032983438     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.6.2941-2950.1999     Document Type: Article

References (44)

1. Abou Zeid, C., T. L. Ratliff, H. G. Wiker, M. Harboe, J. Bennedsen, and G. A. Rook. 1988. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun. 56:3046-3051.
2. Amara, R. R., and V. Satchidanandam. 1996. Analysis of a genomic DNA expression library of Mycobacterium tuberculosis using tuberculosis patient sera: evidence for modulation of the host immune response. Infect. Immun. 64:3765-3771.
3. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
4. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
5. Arachi, A. 1991. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1-6.
6. Baily, G. V. 1981. BCG vaccination after the Madras study. Lancet i:309-310.
7. Barnes, P. F., and S. A. Barrows. 1993. Tuberculosis in the 1990s. Ann. Intern. Med. 119:400-410.
8. Barnes, P. F., V. Mehra, B. Rivoire, S. J. Fong, P. J. Brennan, M. S. Voegtline, P. Minden, R. A. Houghten, B. R. Bloom, and R. L. Modlin. 1992. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J. Immunol. 148:1835-1840.
9. Barnes, P. F., A. B. Bloch, P. T. Davidson, and D. E. Snider, Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650.
10. Braun, M. M., and G. Cauthen. 1992. Relationship of the human immunodeficiency virus epidemic to pediatric tuberculosis and bacillus Calmette-Guerin immunization. Pediatr. Infect. Dis. J. 11:220-227.
11. Calmette, A., C. Guerin, L. Negre, and A. Boquet. 1926. Prémunition des nouveaux-nés contre la tuberculose par le vaccin BCG, 1921-1926. Ann. Inst. Pasteur (Paris) 40:89-133.
12. Chaisson, R. E., G. F. Schecter, C. P. Theuer, G. W. Rutherford, D. F. Echenberg, and P. C. Hopewell. 1987. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am. Rev. Respir. Dis. 136:570-574.
13. Coates, A. R. M., J. Hewitt, B. W. Allen, J. Ivanyi, and D. A. Mitchison. 1981. Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies. Lancet ii:167-169.
14. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdik, H. V. Fineburg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
15. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Conner, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
16. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffen, D. G. Russel, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243-2247.
17. Engers, H. D., V. Houba, J. Bennedsen, T. M. Buchanan, S. D. Chapars, G. Kadival, O. Closs, J. R. David, J. D. A. van Embden, T. Godal, S. A. Mustafa, J. Ivanyi, D. B. Young, S. H. E. Kaufmann, A. G. Komenko, A. H. J. Kolk, M. Kubin, J. A. Louis, P. Minden, T. M. Shinnick, L. Trnka, and R. A. Young. 1986. Results of a World Health Organization sponsored workshop to characterize antigens recognized by mycobacterium-specific monoclonal antibodies. Infect. Immun. 51:718-720.
18. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for IFN-γ in resistance to M. tuberculosis infection. J. Exp. Med. 178:2248-2253.
19. Haslov, K., A. Andersen, S. Nagal, A. Gottschau, T. Sorensen, and P. Andersen. 1995. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect. Immun. 63:804-810.
20. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, and J. Casanova. 1996. Interferon-gamma-receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961.
21. Kochi, A. 1991. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1-6.
22. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
23. Launois, P., R. DeLeys, M. N. Niang, A. Drowart, M. Andrien, P. Dierckx, J. L. Cartel, J. L. Sarthou, J. P. Van Vooren, and K. Huygen. 1994. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
24. Lewinsohn, D. M., M. R. Alderson, A. L. Briden, S. R. Riddell, S. G. Reed, K. H. Grabstein. 1998. Characterization of human CDS+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1633-1640.
25. Matsuo, K., R. Yamaguchi, A. Yamazaki, H. Tasaka, and T. Yamada. 1988. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen. J. Bacteriol. 170:3847-3854.
26. + T cells. Infect. Immun. 55:2037-2041.
27. Narrain, J. P., M. C. Raviglione, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuberc. Lung Dis. 73:311-321.
28. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowkz, B. A. Oostra, R. Williamson, and M. Levin. 1997. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
29. Orme, I. M., and F. M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed type hypersensitivity to tuberculin. Cell. Immunol. 84:113-120.
30. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293-298.
31. Orme, I. M. 1988. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310-3312.
32. Orme, I. 1994. Protective and memory immunity in mice infected with Mycobacterium tuberculosis. Immunobiology 191:503-508.
33. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781-4792.
34. Pedrazanni, T., K. Hug, and J. A. Louis. 1987. Importance of L3T4+ and Lyt-2+ T cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guerin in mice. J. Immunol. 139:2032-2037.
35. Roche, P. W., J. A. Triccas, D. T. Avery, T. Fitis, H. Billman-Jacobe, and W. J. Britton. 1994. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with Bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. J. Infect. Dis. 170:1326-1330.
36. Romain, F., J. Augier, P. Pescher, and G. Marchai. 1993. Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria. Proc. Natl. Acad. Sci. USA 90:5322-5326.
37. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673-5678.
40. Schaaf, H. S., P. Botha, N. Beyers, R. P. Gie, H. A. Vermeulen, P. Groenwald, G. J. Coetzee, and P. R. Donald. 1996. The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa. Trop. Med. Int. Health 1:718-722.
41. Shinnick, T. M. 1987. The 65-kilodalton antigen of Mycobacterium tuberculosis. J. Bacteriol. 169:1080-1088.
42. Skeiky, Y. A. W., J. A. Guderian, D. R. Benson, O. Bacelar, E. M. Carvalho, M. Kubin, R. Badaro, G. Trinchieri, and S. G. Reed. 1995. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med. 181:1527-1537.
43. Von Reyn, C. F., C. J. Clements, and J. M. Mann. 1987. Human immunodeficiency virus infection and routine childhood immunization. Lancet ii: 669-672.
44. Weltman, A. C., and D. N. Rose. 1993. The safety of Bacille Calmette-Guerin vaccination in HIV infection and AIDS. AIDS 7:149-157.